杜邦季績勝預期 斥52億美元收購工程物料製造商
美國化工巨擘杜邦(DuPont))(DD.US)第三季每股盈利爲1.15美元,收入爲43億美,兩者皆優於市場預期,因市場需求強勁及價格上漲,抵銷了更高的原材料成本。
杜邦表示,預計晶片短缺將持續到明年,但情況會較目前有所緩解。
杜邦又宣佈,將以52億美元收購工程物料製造商Rogers(ROG.US),以加強向電動車、5G及清潔能源市場的原材料供應。
另外,公司亦計劃出售週期性流動及原材料部分的大部分業務,包括DuPont Teijin薄膜合營公司的股權。
杜邦昨晚股價高見78.19美元,收報77.49美元,升8.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.